Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma

被引：0
|
作者：
Walewski, Jan [1 ]
Paszkiewicz-Kozik, Ewa [1 ]
Warszewska, Agnieszka [1 ]
Borsaru, Gabriela [2 ]
Moicean, Andreea [3 ]
Hellmann, Andrzej [4 ]
Mayer, Jiri [5 ,6 ]
Hauns, Bernhard [7 ]
Mais, Anna [7 ]
Henning, Stefan W. [7 ]
Hentsch, Bernd [7 ]
机构：
[1] Maria Sklodowska Curie Mem Inst & Oncol Ctr, Warsaw, Poland
[2] Spitalul Clin Coltea, Bucharest, Romania
[3] Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania
[4] Med Univ Gdansk, Gdansk, Poland
[5] Univ Hosp Brno, Dept Internal Med Hematooncol, Brno, Czech Republic
[6] CEITEC Masaryk Univ, Brno, Czech Republic
[7] 4SC AG, Martinsried, Germany
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1149 / 1149
页数：1
相关论文
共 50 条
  • [31] Preliminary Results of a Phase II Trial with the Multikinase Inhibitor Sorafenib in Heavily Pretreated Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL).
    Guidetti, Anna
    Carlo-Stella, Carmelo
    Devizzi, Liliana
    Matteucci, Paola
    Marchiano, Alfonso
    Lanocita, Rodolfo
    Magni, Michele
    Dodero, Anna
    Tarella, Corrado
    Di Nicola, Massimo
    Corradini, Paolo
    Gianni, Alessandro M.
    BLOOD, 2009, 114 (22) : 662 - 662
  • [32] Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma
    Di Bella, Nicholas
    Taetle, Raymond
    Kolibaba, Kathryn S.
    Boyd, Thomas E.
    Raju, Robert N.
    Barrera, David N.
    Cochran, Ernest
    Dien, Philip
    Hakimian, David
    Lyons, Roger M.
    Schlegel, Peter J.
    Vukelja, Svetislava J.
    Boston, Julie
    Boehm, Kristi A.
    Wang, Yunfei
    Asmar, Lina
    BLOOD, 2008, 112 (11) : 558 - 558
  • [33] A Phase II Multicenter Study of Lenalidomide in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL): Preliminary Results.
    Fehniger, Todd A.
    Larson, Sarah
    Trinkaus, Kathryn
    Siegel, Marilyn J.
    DiPersio, John F.
    Cashen, Amanda F.
    Hurd, David D.
    Blum, Kristie A.
    Bartlett, Nancy L.
    BLOOD, 2008, 112 (11) : 899 - 900
  • [34] Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)
    Morrison, Vicki A.
    Jung, Sin-Ho
    Johnson, Jeffrey
    LaCasce, Ann
    Blum, Kristie A.
    Bartlett, Nancy L.
    Pitcher, Brandelyn N.
    Cheson, Bruce D.
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 958 - 964
  • [35] Final results of the phase II trial of paclitaxel plus oral estramustine phosphate in patients with relapsed aggressive non-Hodgkin's Lymphoma.
    Borghaei, H
    Millenson, MM
    Schilder, RJ
    Rogatko, A
    Alden, M
    Wang, H
    Padavic-Shaller, KA
    Minnitti, C
    Smith, MR
    BLOOD, 2003, 102 (11) : 293B - 293B
  • [36] A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma
    Cohen, Jonathon B.
    Maddocks, Kami J.
    Huang, Ying
    Christian, Beth A.
    Jaglowski, Samantha M.
    Flowers, Christopher R.
    Blum, Kristie A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2268 - 2269
  • [37] A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
    Hanel, Walter
    Shindiapina, Polina
    Bond, David A.
    Sawalha, Yazeed
    Epperla, Narendranath
    Voorhees, Timothy
    Welkie, Rina Li
    Huang, Ying
    Behbehani, Gregory K.
    Zhang, Xiaoli
    McLaughlin, Eric
    Chan, Wing K.
    Brammer, Jonathan E.
    Jaglowski, Samantha
    Reneau, John C.
    Christian, Beth A.
    William, Basem M.
    Cohen, Jonathon B.
    Baiocchi, Robert A.
    Maddocks, Kami
    Blum, Kristie A.
    Alinari, Lapo
    CANCERS, 2023, 15 (05)
  • [38] A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
    Hanel, Walter
    Christian, Beth A.
    Maddocks, Kami J.
    Epperla, Narendranath
    William, Basem M.
    Jaglowski, Samantha
    Bond, David A.
    Sawalha, Yazeed
    Reneau, John C.
    Brammer, Jonathan E.
    Baiocchi, Robert
    Blum, Kristie A.
    Alinari, Lapo
    BLOOD, 2020, 136
  • [39] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [40] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345